tiprankstipranks
Advertisement
Advertisement

KPTI Stock Latest News

Karyopharm says Phase 3 SENTRY trial selected for presentation at EHA 2026
The FlyKaryopharm says Phase 3 SENTRY trial selected for presentation at EHA 2026
5d ago
KPTI
Karyopharm’s selinexor combination shows efficacy in myelofibrosis
PremiumThe Fly
Karyopharm’s selinexor combination shows efficacy in myelofibrosis
5d ago
KPTI
Karyopharm Expands Equity Incentives and Launches PSU Program
PremiumCompany Announcements
Karyopharm Expands Equity Incentives and Launches PSU Program
10d ago
8K
KPTI
Karyopharm (KPTI) Leans on SENTRY in Pivotal Call
PremiumCompany Announcements
Karyopharm (KPTI) Leans on SENTRY in Pivotal Call
19d ago
KPTI
Karyopharm Earnings Call: Trial Wins, Cash Questions
PremiumCompany Announcements
Karyopharm Earnings Call: Trial Wins, Cash Questions
24d ago
KPTI
Karyopharm reports Q1 EPS ($1.24), consensus ($1.44)
PremiumThe FlyKaryopharm reports Q1 EPS ($1.24), consensus ($1.44)
24d ago
KPTI
Karyopharm sees 2026 revenue $130M-$150M, consensus $137.49M
Premium
The Fly
Karyopharm sees 2026 revenue $130M-$150M, consensus $137.49M
24d ago
KPTI
Karyopharm price target raised to $13 from $8 at H.C. Wainwright
Premium
The Fly
Karyopharm price target raised to $13 from $8 at H.C. Wainwright
1M ago
KPTI
Karyopharm files $400M mixed securities shelf
PremiumThe Fly
Karyopharm files $400M mixed securities shelf
1M ago
KPTI
Karyopharm files to sell 8.84M shares of common stock for holders
PremiumThe Fly
Karyopharm files to sell 8.84M shares of common stock for holders
1M ago
KPTI
KPTI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
KPTI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
KPTI
Karyopharm price target raised to $16 from $8 at Piper Sandler
PremiumThe Fly
Karyopharm price target raised to $16 from $8 at Piper Sandler
1M ago
KPTI
Karyopharm price target lowered to $16 from $23 at RBC Capital
PremiumThe FlyKaryopharm price target lowered to $16 from $23 at RBC Capital
2M ago
KPTI
Karyopharm price target lowered to $8 from $12 at Piper Sandler
Premium
The Fly
Karyopharm price target lowered to $8 from $12 at Piper Sandler
2M ago
KPTI
Karyopharm Strengthens Liquidity With New Equity Financing
Premium
Company Announcements
Karyopharm Strengthens Liquidity With New Equity Financing
2M ago
8K
KPTI
Karyopharm price target lowered to $15 from $21 at Baird
PremiumThe Fly
Karyopharm price target lowered to $15 from $21 at Baird
2M ago
KPTI
Karyopharm price target lowered to $8 from $15 at H.C. Wainwright
PremiumThe Fly
Karyopharm price target lowered to $8 from $15 at H.C. Wainwright
2M ago
KPTI
Karyopharm Announces Financing and Positive SENTRY Trial Results
PremiumCompany Announcements
Karyopharm Announces Financing and Positive SENTRY Trial Results
3M ago
8K
KPTI
Karyopharm up 23% after Phase 3 SENTRY trial meets first co-primary endpoint
PremiumThe Fly
Karyopharm up 23% after Phase 3 SENTRY trial meets first co-primary endpoint
3M ago
KPTI
Karyopharm’s Phase 3 SENTRY trial meets first co-primary endpoint
PremiumThe FlyKaryopharm’s Phase 3 SENTRY trial meets first co-primary endpoint
3M ago
KPTI
Karyopharm announces $30M private placement
Premium
The Fly
Karyopharm announces $30M private placement
3M ago
KPTI
Karyopharm initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Karyopharm initiated with a Buy at Rodman & Renshaw
3M ago
KPTI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >